Skip to main content
. 2021 Aug 11;27(19):5317–5324. doi: 10.1158/1078-0432.CCR-21-1239

Table 1.

HER2 status as a predictor of recurrence: categorized (negative, equivocal, positive) and binary (negative, positive).

Reference IHC 0, 1+ Reference IHC 0, 1+, 2+
Univariate Multivariate Univariate Multivariate
Endpoint Events HER2 HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
IBE 147a IHC 2+ 2.77 (1.70–4.54) <0.0001 2.76 (1.63–4.66) 0.0001
IHC 3+ 2.90 (2.02–4.17) <0.0001 2.46 (1.64–3.68) <0.0001 2.27 (1.64–3.14) <0.0001 1.92 (1.33–2.76) 0.0004
I-IBE 54 IHC 2+ 2.08 (0.97–4.47) 0.061 1.99 (0.88–4.52) 0.10
IHC 3+ 1.63 (0.91–2.92) 0.10 1.40 (0.73–2.70) 0.31 1.40 (0.81–2.42) 0.23 1.21 (0.65–2.23) 0.55
DCIS-IBE 91 IHC 2+ 3.49 (1.82–6.69) 0.0002 3.52 (1.77–6.99) 0.0003
IHC 3+ 4.03 (2.47–6.58) <0.0001 3.28 (1.91–5.61) <0.0001 2.90 (1.91–4.40) <0.0001 2.34 (1.47–3.74) 0.0003

aRecurrence type not known in two cases. Multivariate analyses are in a smaller number of samples (n = 612) due to non-available clinicopathological data in some samples.